Bard PowerPort Lawsuits
The Bard PowerPort is a type of catheter implanted into the body to access the vascular system. The Ports deliver medicine, chemotherapy, nutrition and withdraw blood when necessary. However, the ports can fail in the following ways:
- Fracturing into pieces inside the vessels
- Causing serious infections
- Causing blood clots
After the ports are implanted, cracks and fractures appear, allowing bacteria to cause infections and potential for forming blood clots.
The manufacturer of the Bard PowerPort devices is C.R. Bard, a subsidiary of Becton Dickinson and Co. Lawsuits allege that Bard PowerPorts can cause serious life-threatening complications, including blood clots, infections, and organ damage, The Food and Drug Administration has received hundreds of adverse event reports from patients implanted with Bard PowerPorts, but the manufacturer continues to market the products as safe and effective without recalling them, adjusting the product, or adding warnings to the label.
Thousands of cases have been filed in the implanted port catheter multidistrict litigation in the U.S. District Court of Arizona. Others are filed in New Jersey and in state court in Arizona. One Bard PowerPort trial is set for August 2026, and six trials are scheduled to begin in March 2026 in the Federal Court of Arizona MDL.
Free Consultation Now
Contact us for a free medical legal consultation now at 800-814-4540 or email carolyn@carolynstclair.com. You may qualify for compensation, but you must act.

